| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 12.351 | 14.960 | 43.185 | 79.757 | 181.601 | 198.057 | 302.108 | 296.241 | 396.428 | 488.156 |
| Total Income - EUR | 12.967 | 15.027 | 165.114 | 79.821 | 181.625 | 198.058 | 302.110 | 296.249 | 396.429 | 488.157 |
| Total Expenses - EUR | 7.973 | 4.813 | 21.169 | 27.708 | 29.810 | 32.449 | 52.569 | 48.787 | 67.299 | 113.119 |
| Gross Profit/Loss - EUR | 4.994 | 10.214 | 143.945 | 52.113 | 151.815 | 165.609 | 249.540 | 247.461 | 329.130 | 375.038 |
| Net Profit/Loss - EUR | 4.575 | 9.764 | 142.294 | 51.315 | 150.098 | 164.136 | 247.389 | 245.127 | 326.017 | 360.686 |
| Employees | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 2 |
Check the financial reports for the company - Imomedica Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 525 | 258 | 1.022 | 2.320 | 633 | 0 | 0 | 87.950 |
| Current Assets | 52.938 | 63.994 | 147.810 | 194.511 | 340.965 | 379.042 | 484.396 | 265.179 | 333.283 | 362.181 |
| Inventories | 690 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 42.573 | 60.308 | 142.874 | 148.438 | 320.345 | 368.980 | 462.008 | 249.493 | 330.077 | 302.329 |
| Cash | 9.675 | 3.686 | 4.936 | 46.073 | 20.620 | 10.061 | 22.388 | 15.685 | 3.207 | 59.851 |
| Shareholders Funds | 41.553 | 50.902 | 142.347 | 191.049 | 337.447 | 375.797 | 476.884 | 245.176 | 326.066 | 360.734 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 11.385 | 13.092 | 5.988 | 3.720 | 4.540 | 5.565 | 8.145 | 20.002 | 7.217 | 89.397 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Imomedica Srl